[go: up one dir, main page]

ES8505966A1 - Un procedimiento para la preparacion de compuestos de bencimidazol - Google Patents

Un procedimiento para la preparacion de compuestos de bencimidazol

Info

Publication number
ES8505966A1
ES8505966A1 ES534218A ES534218A ES8505966A1 ES 8505966 A1 ES8505966 A1 ES 8505966A1 ES 534218 A ES534218 A ES 534218A ES 534218 A ES534218 A ES 534218A ES 8505966 A1 ES8505966 A1 ES 8505966A1
Authority
ES
Spain
Prior art keywords
procedure
preparation
compounds
benzmidazole
alcanoyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES534218A
Other languages
English (en)
Other versions
ES534218A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of ES534218A0 publication Critical patent/ES534218A0/es
Publication of ES8505966A1 publication Critical patent/ES8505966A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE COMPUESTOS DE BENCIMIDAZOL.CONSISTE EN ACILAR A UN COMPUESTO DE FORMULAS (I) SIENDO (R1FH) CON UN AGENTE ACILANTE COMO HALURO DE ALCANOILO DE C1 A 4, CLORURO DE ACETILO Y OTROS, PARA OBTENER A (I) SIENDO (R1F ALCANOILO DE C1 A 4) Y SUS SALES DE ADICION FARMACEUTICAMENTE ACEPTABLES. SIENDO R2,H, SO2R3 Y OTROS; R3, ALQUILO DE C1 A 5, CICLOALQUILO DE C3 A 7 Y OTROS; R7, H, ALQUILO DE C1 A 7, CICLOALQUILO DE C3 A 7 Y OTROS Y R8 Y R9, INDEPENDIENTES ENTRE SI, H, HAL, CIANO, NITRO Y OTROS.SE UTILIZAN PARA EL TRATAMIENTO Y CONTROL DEL CRECIMIENTO VIRICO.
ES534218A 1982-04-08 1984-07-11 Un procedimiento para la preparacion de compuestos de bencimidazol Expired ES8505966A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/366,760 US4420479A (en) 1982-04-08 1982-04-08 Olefinic benzimidazoles, formulations, and antiviral methods

Publications (2)

Publication Number Publication Date
ES534218A0 ES534218A0 (es) 1985-06-01
ES8505966A1 true ES8505966A1 (es) 1985-06-01

Family

ID=23444387

Family Applications (2)

Application Number Title Priority Date Filing Date
ES521318A Expired ES8502097A1 (es) 1982-04-08 1983-04-07 Un procedimiento para la preparacion de compuestos de bencimidazol.
ES534218A Expired ES8505966A1 (es) 1982-04-08 1984-07-11 Un procedimiento para la preparacion de compuestos de bencimidazol

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES521318A Expired ES8502097A1 (es) 1982-04-08 1983-04-07 Un procedimiento para la preparacion de compuestos de bencimidazol.

Country Status (18)

Country Link
US (1) US4420479A (es)
EP (1) EP0091795A1 (es)
KR (1) KR840004409A (es)
AU (1) AU1322483A (es)
CA (1) CA1197245A (es)
DD (1) DD209624A5 (es)
DK (1) DK152883A (es)
ES (2) ES8502097A1 (es)
FI (1) FI831191A7 (es)
GB (1) GB2119789B (es)
GR (1) GR78168B (es)
IL (1) IL68299A0 (es)
NZ (1) NZ203798A (es)
PH (1) PH18108A (es)
PL (3) PL241385A1 (es)
PT (1) PT76499B (es)
RO (1) RO86319B (es)
ZA (1) ZA832410B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE144142T1 (de) * 1991-01-10 1996-11-15 Transcend Therapeutics Inc Verwendung von thiazolidin-4-carboxylatderivaten zur behandlung von lungenerkrankungen
US5747459A (en) * 1991-02-04 1998-05-05 Nestec, Ltd. Method for insuring adequate intracellular glutathione in tissue
US5430045A (en) * 1992-04-23 1995-07-04 Free Radical Sciences, Inc. Method of reducing or preventing bone marrow hypoplasia
JP2787539B2 (ja) * 1993-02-26 1998-08-20 松森　　昭 ウイルス性疾患の予防または治療剤
US5447712A (en) * 1993-12-09 1995-09-05 Free Radical Sciences Method of reducing cyclophosphamide induced hemorrhagic cystitis
US5475109A (en) * 1994-10-17 1995-12-12 Merck & Co., Inc. Dioxobutanoic acid derivatives as inhibitors of influenza endonuclease
US5545653A (en) * 1995-06-07 1996-08-13 Eli Lilly And Company Anti-viral compounds
US5693661A (en) * 1995-06-07 1997-12-02 Eli Lilly And Company Anti-viral compounds
US5891874A (en) * 1996-06-05 1999-04-06 Eli Lilly And Company Anti-viral compound
JP2000511899A (ja) * 1996-06-05 2000-09-12 イーライ・リリー・アンド・カンパニー 抗―ウイルス性化合物群
US5821242A (en) * 1996-06-06 1998-10-13 Eli Lilly And Company Anti-viral compounds
KR100539031B1 (ko) 1996-08-12 2005-12-27 셀진 코포레이션 면역치료제 및 이를 이용하여 사이토카인 농도를감소시키는 방법
WO1998031363A1 (en) * 1997-01-22 1998-07-23 Eli Lilly And Company Anti-viral compounds
EP1001767A4 (en) * 1997-06-04 2001-07-04 Lilly Co Eli ANTIVIRAL CONNECTIONS
US7470723B2 (en) 2003-03-05 2008-12-30 Celgene Corporation Diphenylethylene compounds and uses thereof
BRPI0408005A (pt) 2003-03-05 2006-02-14 Celgene Corp composto, composição farmacêutica, métodos para inibir angiogênese, atividade de pde4 em uma célula e proliferação de célula de cáncer, para inibir ou reduzir polimerização de tubulina ou estabilidade de tubulina em uma célula, para tratar ou melhorar um distúrbio inflamatório, um cáncer e um distúrbio do sistema nervoso central e para visar, bloquear ou destruir a função de vasculatura de tumor e o endotélio de vasos de tumor
WO2006028963A2 (en) 2004-09-03 2006-03-16 Celgene Corporation Substituted heterocyclic compounds and uses thereof
CN108997158B (zh) * 2018-07-16 2020-12-15 青岛科技大学 一种实现二取代酰胺与二苯基甲酮偶联的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4018790A (en) * 1975-05-08 1977-04-19 Eli Lilly And Company Substituted 1-sulfonylbenzimidazoles
US4174454A (en) * 1975-08-28 1979-11-13 Eli Lilly And Company Alkylidenylmethyl-substituted 1-sulfonylbenzimidazoles
MX3654E (es) * 1975-08-28 1981-04-14 Lilly Co Eli Procedimiento para preparar compuestos de sulfonilbencimidazol
CA1076582A (en) * 1975-10-28 1980-04-29 Charles J. Paget Antiviral thiazolinyl or thiazinyl ketobenzimidazoles
US4008243A (en) * 1975-11-19 1977-02-15 Eli Lilly And Company Antiviral thiazolinyl or thiazinyl benzimidazole esters
US4118573A (en) * 1975-11-24 1978-10-03 Eli Lilly And Company Substituted 1-sulfonylbenzimidazoles
GR66420B (es) * 1976-12-15 1981-03-20 Lilly Co Eli
US4230868A (en) * 1979-04-17 1980-10-28 Eli Lilly And Company α-Alkyl-α-hydroxybenzyl-substituted 1-sulfonylbenzimidazoles
US4316021A (en) * 1979-08-13 1982-02-16 Eli Lilly And Company Substituted 1-sulfonylbenzimidazoles

Also Published As

Publication number Publication date
PH18108A (en) 1985-03-22
US4420479A (en) 1983-12-13
AU1322483A (en) 1983-10-13
FI831191L (fi) 1983-10-09
ES521318A0 (es) 1984-12-16
PL241385A1 (en) 1984-09-24
PL247908A1 (en) 1985-01-16
ES534218A0 (es) 1985-06-01
NZ203798A (en) 1985-07-12
ES8502097A1 (es) 1984-12-16
RO86319B (ro) 1985-03-31
DK152883A (da) 1983-10-09
FI831191A0 (fi) 1983-04-08
DD209624A5 (de) 1984-05-16
EP0091795A1 (en) 1983-10-19
PT76499B (en) 1986-03-18
FI831191A7 (fi) 1983-10-09
RO86319A (ro) 1985-03-15
PT76499A (en) 1983-05-01
DK152883D0 (da) 1983-04-06
IL68299A0 (en) 1983-07-31
GR78168B (es) 1984-09-26
GB2119789A (en) 1983-11-23
ZA832410B (en) 1984-11-28
KR840004409A (ko) 1984-10-15
PL247909A1 (en) 1984-12-17
CA1197245A (en) 1985-11-26
GB2119789B (en) 1985-08-29

Similar Documents

Publication Publication Date Title
ES8505966A1 (es) Un procedimiento para la preparacion de compuestos de bencimidazol
ES8407049A1 (es) Un procedimiento para la preparacion de compuestos biciclicos.
ES8504140A1 (es) Procedimiento para la preparacion de nuevos bencimidazoles substituidos
ES477695A1 (es) Un procedimiento para preparar derivados de deshidrociclici-minoacidos.
ES2040261T3 (es) Procedimiento para preparar acidos 6-fluor-4-oxo-1,4-dihidroquinolina-3-carboxilicos sustituidos y acidos 9-fluor-3-metil-7-oxo-2,3-dihidro-7h-pirido(1,2,3-de)(1,4)benzoxazina-6-carboxilico sustituidos.
ES8602022A1 (es) Un procedimiento para preparar un derivado de 4'-dimetil-4-epipodofilotoxina
AR241531A1 (es) Un procedimiento para la preparacion derivados de 2-indolinona, y sus sales farmaceuticamente aceptables.
ES8603497A1 (es) Procedimiento para preparar derivados de cefalosporina
ES8801284A1 (es) Procedimiento para preparar nuevos compuestos de benzotiofeno y benzofurano
AR009612A1 (es) Una composicion farmaceutica, un diaril-ciclometilenpirazol, un procedimiento para preparar un diaril-ciclometilenpirazol y comuestosintermedios
ES2038074A1 (es) Nuevos derivados de benzimidazol, su preparacion y su aplicacion como medicamentos.
DK161382C (da) Fremgangsmaade til fremstilling af 1,2,4-triazol-forbindelser eller farmaceutisk acceptable syreadditionssalte deraf
ES8607299A1 (es) Procedimiento para preparar (2-oxo-1,2,3,5-tetrahidroimida- zo(2,1-b)quinazolinil)-oxialquilamidas
ES8304919A1 (es) Un procedimiento para la preparacion de dicloroamino-acidos.
ES8801622A1 (es) Un procedimiento para preparar derivados arilicos de dienamidas
FI812804L (fi) 2-(1,4-bensodioxan-2-ylalkyl)-imidazoler anvaendbara som antidepressiva laekemedel
ES8401965A1 (es) Un procedimiento para la preparacion de un derivado de piridoindol.
KR840003631A (ko) 아졸릴펜옥시- 테트라하이드로푸란-2-일리덴- 메탄의 제조방법
ES2058795T3 (es) Heterociclilguanidinas como antagonistas 5ht3.
ES2038684T3 (es) Procedimiento de preparacion de derivados de octahidroindol y de compuestos intermedios de su preparacion.
ES442007A1 (es) Procedimiento para la preparacion de nuevos derivados 4-sus-tituidos de difenileter.
ES440386A1 (es) Procedimiento para la preparacion de 2-carbalcoxi-amino-5 (6)-fenilsulfoniloxibencimidazoles.
ES8505199A1 (es) Un procedimiento para la preparacion de derivados de difenilalquilenicos.
ES462643A1 (es) Procedimiento para la preparacion de compuestos antraquini- nicos.
ES8401761A1 (es) Un procedimiento para la preparacion de derivados de 1-(3,4,5-trimetoxicinamoil)-4-aminocarboniletil-piperazina sustituidos.